The causes of adverse changes of testosterone levels in men

References

• Duration of life. 2019. [cited 2020 Oct 1]. Available from: https://stat.gov.pl/obszary-tematyczne/ludnosc/trwanie-zycia/trwanie-zycia-tablice,1,1.html
   Google Scholar
• Morales A, Schulman CC, Tostain J, et al. Testosterone deficiency syndrome (TDS) needs to be named appropriately the importance of accurate terminology. Eur Urol. 2006;50(3):407–409.
   PubMed Web of Science ®Google Scholar
• O’Donnell L, Stanton P, de Kretser DM, et al. Endocrinology of the male reproductive system and Spermatogenesis. [updated 2017 Jan 11]. In: Feingold KR, Anawalt B, Boyce A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. p.11-22.
   Google Scholar
• Andersen ML, Alvarenga TF, Mazuro-Costa R, et al. The association of testosterone, sleep, and sexual function in men and women. Brain Res. 2011;1416:80–104.
   PubMed Web of Science ®Google Scholar
• Durdiakova J, Ostatnikova D, Celec P. Testosterone and its metabolites – modulators o brain functions. Acta Neurobiol Exp. 2011;71:434–454.
   PubMed Web of Science ®Google Scholar
• Newton DE. Steroids and doping in sports: a reference handbook. Santa Barbara: ABC-CLIO; 2014. p. 10–37.
   Google Scholar
• Nieschlag E, Nieschlag S, Luetjens CM, et al. Testosterone: action, deficiency, substitution. New York: Cambridge Univesity Press; 2012. p. 15–32 33–59 177–191 191–207 207–235.
   Google Scholar
• Neumister B, Besenthal I, Böhm BO. Diagnostyka Laboratoryjna [Diagnostic laboratory]. Wroclaw: Elsevier Urban & Partner; 2013. p. 91–126.
   Google Scholar
• Murray RK. Harper’s illustrated biochemistry. Warsaw: PZWL; 2008. p. 282–285.
   Google Scholar
• Keevil BG, Adaway JO. Assessment of free testosterone concentration. J Steroid Biochem Mol Biol. 2019;190:207–211.
   PubMed Web of Science ®Google Scholar
• Parr MK, Flenker U, Schanzer W. Sports-related issues and biochemistry of natural and synthetic anabolic substances. Endocrinol Metab Clin. 2010;39(1):45–57.
   Google Scholar
• Feige P, Brun CE, Ritso M, et al. Orienting muscle stem cells for regeneration in homeostasis, aging, and disease. Cell Stem Cell. 2018;23(5):653–664.
   PubMed Web of Science ®Google Scholar
• Wood RI, Stanton SJ. Testosterone and sport: current perspectives. Horm Behav. 2012;61(1):147–155.
   PubMed Web of Science ®Google Scholar
• Kadi F. Cellular and molecular mechanism responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement. Br J Pharmacol. 2008;154:522–528.
   PubMed Web of Science ®Google Scholar
• Medras M, Józków P. Zastosowanie testosteronu i steroidów androgenno-anabolicznych w sporcie. Endokrynol Pol. 2009;60(3):204–209.
   PubMedGoogle Scholar
• Wittert G. The relationship between sleep disorders and testosterone in men. Asian J Androl. 2014;16(2):262–265.
   PubMed Web of Science ®Google Scholar
• Tuck SP, Francis RM. Testosterone, bone and osteoporosis. Front Horm Res. 2009;37:123–132.
   PubMed Web of Science ®Google Scholar
• Hoffman JR, Kraemer WJ, Bhasin S, et al. Position stand on androgen and human growth hormone use. J Strength Cond Res. 2009;23:1–59.
   PubMed Web of Science ®Google Scholar
• Finkelstein JS, Lee H, Burnett-Bowie SM, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011–1022.
   PubMed Web of Science ®Google Scholar
• Vanderschueren D, Gaytant J, Boonen S, et al. Androgens and bone. Curr Opin Endocrinol Diabetes Obes. 2008;15(3):250–254.
   PubMedGoogle Scholar
• Carre JM, Geniole SN, Ortiz TL, et al. Exogenous testosterone rapidly increases aggressive behavior in dominant and impulsive men. Biol Psychiatry. 2017;82(4):249–256.
   PubMed Web of Science ®Google Scholar
• Probst F, Golle J, Lory V, et al. Reactive aggression tracks within-participant changes in women's salivary testosterone. Aggress Behav. 2018;44(4):1–10.
   Web of Science ®Google Scholar
• Gromadzka-Ostrowska J, Dworznicki J. Wplyw deficytu energetycznego na wybrane parametry hormonalne i lipidowe osocza krwi mlodych mezczyzn. Nowa Med.. 2002;71:222–225.
   Google Scholar
• Cangemi R, Friedmann AJ, Holloszy JO, et al. Long-term effects of calorie restriction on serum sex-hormone concentrations in men. Aging Cell. 2010;9(2):236–242.
   PubMed Web of Science ®Google Scholar
• Kumagai H, Zempo-Miyaki A, Yoshikawa T, et al. Increased physical activity has a greater effect than reduced energy intake on lifestyle modification-induced increases in testosterone. J Clin Biochem Nutr. 2016;58(1):84–89.
   PubMed Web of Science ®Google Scholar
• Khoo J, Ling PS, Tan J, et al. Comparing the effects of meal replacements with reduced-fat diet on weight, sexual and endothelial function, testosterone and quality of life in obese Asian men. Int J Impot Res. 2014;26(2):61–66.
   PubMed Web of Science ®Google Scholar
• Schulte DM, Hahn M, Oberhauser F, et al. Caloric restriction increases serum testosterone concentrations in obese male subjects by two distinct mechanisms. Horm Metab Res. 2014;46(4):283–286.
   Web of Science ®Google Scholar
• Debjit B, Chiranjib KP, Sampath K. A potential medicinal importance of zinc in human health and chronic disease. Int J Pharm. 2010;1:5–11.
   Google Scholar
• Jalali GR, Roozbeh J, Mohammadzadeh A, et al. Impact of oral zinc therapy on the level of sex hormones in male patients on hemodialysis. Ren Fail. 2010;32(4):417–419.
   PubMed Web of Science ®Google Scholar
• Jauch-Chara K, Schmid SM, Hallschmid M, et al. Pituitary-gonadal and pituitary-thyroid axis hormone concentrations before and during a hypoglycemic clamp after sleep deprivation in healthy men. PLoS One. 2013;8(1):542–549.
   Web of Science ®Google Scholar
• Kaufmann JM, Vermeulen A. The decline of androgens levels in elderly men and its clinical and therapeutic implications. Endocr Rev. 2005;26:833–876.
   PubMed Web of Science ®Google Scholar
• Santos HO, Teixeira FJ. Use of medicinal doses of zinc as a safe and efficient coadjutant in the treatment of male hypogonadism. Aging Male. 2019 Feb;15:1–10.
   Google Scholar
• Prasad AS, Mantzoros CS, Beck FW, et al. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344–348.
   PubMed Web of Science ®Google Scholar
• Kilic M, Baltaci AK, Gunay M, et al. The effect of exhaustion exercise on thyroid hormones and testosterone levels of elite athletes receiving oral zinc. Neuro Endocrinol Lett. 2006;27:247–252.
   PubMed Web of Science ®Google Scholar
• Koehler K, Parr MK, Geyer H, et al. Serum testosterone and urinary excretion of steroid hormone metabolites after administration of a high-dose zinc supplement. Eur J Clin Nutr. 2009;63(1):65–70.
   PubMed Web of Science ®Google Scholar
• Maggio M, Ceda GP, Lauretani F, et al. Magnesium and anabolic hormones in older men. Int J Androl. 2011;34(6pt2):594–600.
   PubMedGoogle Scholar
• Cinar V, Polat Y, Baltaci AK, et al. Effects of magnesium supplementation on testosterone levels of athletes and sedentary subjects at rest and after exhaustion. Biol Trace Elem Res. 2011;140(1):18–23.
   PubMed Web of Science ®Google Scholar
• Golf SW, Happel O, Graef V, et al. Plasma aldosterone, cortisol and electrolyte concentrations in physical exercise after magnesium supplementation. J Clin Chem Clin Biochem. 1984;22(11):717–721.
   PubMedGoogle Scholar
• Lane A, Duke JW, Hackney AC. Influence of dietary carbohydrate intake on the free testosterone: cortisol ratio responses to short-therm intensive exercise training. Eur J Appl Physiol. 2010;108(6):1125–1131.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Corticosteroid effects on cell signaling. Eur Respir J. 2006;27(2):413–426.
   PubMed Web of Science ®Google Scholar
• Van Der Laan S, Meijer OC. Pharmacology of glucocorticoids: beyond receptors. Eur J Pharmacol. 2008;585(2–3):483–491.
   PubMed Web of Science ®Google Scholar
• Roland AV, Moenter SM. Regulation of gonadotropin-releasing hormone neurons by glucose. Trends Endocrinol Metab. 2011;22(11):443–449.
   PubMed Web of Science ®Google Scholar
• Blomberg JM, Nielsen JE, Jorgensen A, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25:1303–1311.
   PubMed Web of Science ®Google Scholar
• Lee MD, Tajar A, Pye RS. Association of hypogonadism with vitamin D status: the European male ageing study. Eur J Endocrinol. 2010;1:77–85.
   Google Scholar
• Wehr E, Pilz S, Boehm BO, et al. Association of vitamin D status with serum androgen levels in men. Clin Endocrinol. 2010;73:243–248.
   PubMed Web of Science ®Google Scholar
• Nimptsch K, Platz A, Willet WC, et al. Association between plasma 25-OH vitamin D and testosterone levels in men. Clin Endocrinol. 2012;77(1):106–112.
   PubMed Web of Science ®Google Scholar
• Canguven O, Talib RA, El Ansari W, et al. Vitamin D treatment improves levels of sexual hormones, metabolic parameters and erectile function in middle-aged vitamin D deficient men. Aging Male. 2017 Mar;20(1):9–16.
   PubMed Web of Science ®Google Scholar
• Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223–225.
   PubMed Web of Science ®Google Scholar
• Neves MAC, Dinis TCP, Colombo G, et al. Combining computational and biochemical studies for a rationale on the anti-aromatase activity of natural polyphenols. Chem Med Chem. 2007;2:1750–1762.
   Google Scholar
• Balunas MJ, Su B, Brueggemeier RW, et al. Natural products as aromatase inhibitors. Anticancer Agents Med Chem. 2008;8(6):646–682.
   PubMed Web of Science ®Google Scholar
• Kijima I, Phung S, Hur G, et al. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression. Cancer Res. 2006;66(11):5960–5967.
   PubMed Web of Science ®Google Scholar
• Longcope C, Feldman HA, McKinlay B. Diet and sex hormone-binding Globulin. J Clin Endocrinol Metab. 2010;85(1):293–296.
   Google Scholar
• Tanskanen MM, Kyrolainen H, Uusitalo AL, et al. Serum sex hormone-binding globulin and cortisol concentrations are associated with overreaching during strenuous military training. J Strength Cond Res. 2011;25(3):787–797.
   PubMed Web of Science ®Google Scholar
• Vaara JP, Kaliomaa R, Hynninen P, et al. Physical fitness and hormonal profile during an 11-week paratroop training period. J Strength Cond Res. 2015;29:S163–S167.
   Web of Science ®Google Scholar
• Bedgood D, Boggiano M, Turan B. Testosterone and social evaluative stress: the moderating role of basal cortisol. Psychoneuroendocrinology. 2014;47:107–115.
   PubMed Web of Science ®Google Scholar
• Chichinadze K, Chichinadze N. Stress induced of testosterone: contributions of social status and sympathetic reactivity. Elsevier. 2008;94:595–603.
   Google Scholar
• Turan B, Tackett JL, Lechtreck MT, et al. Coordination of the cortisol and testosterone responses: A dual axis approach to understanding the response to social status threats. Psychoneuroendocrinology. 2015;62:59–68.
   PubMed Web of Science ®Google Scholar
• Chan J, Sauve B, Tokmakejian S, et al. Measurement of cortisol and testosterone in hair of obese and non-obese human subjects. Exp Clin Endocrinol Diabetes. 2014;122(6):356–362.
   PubMed Web of Science ®Google Scholar
• Santilli F, Liani R, Di Fulvio P, et al. Increased circulating resistin is associated with insulin resistance, oxidative stress and platelet activation in type 2 diabetes mellitus. ThrombHaemost. 2016;116:1089–1099.
   Google Scholar
• Solis-Paredes M, Estrada-Gutierrez G, Perichart-Perera O, et al. Key clinical factors predicting adipokine and oxidative stress marker concentrations among normal, overweight and obese pregnant women using artificial neural networks. Int J Mol Sci. 2017;19(1):86–91.
   Web of Science ®Google Scholar
• Raff H, Hoeynck B, Jablonski M, et al. Insulin sensitivity, leptin, adiponectin, resistin, and testosterone in adult male and female rats after maternal-neonatal separation and environmental stress. Am J Physiol Regul Integr Comp Physiol. 2018;314(1):12–21.
   Web of Science ®Google Scholar
• Rovira-Liopis S, Banuls C, Maranon A, et al. Low testosterone levels are related to oxidative stress, mitochondrial dysfunction and altered subclinical atherosclerotic markers in type 2 diabetic male patients. Free Radic Biol Med. 2017;108:155–162.
   PubMed Web of Science ®Google Scholar
• Bedgood D, Boggiano MM, Turan B. Testosterone and social evaluative stress: the moderating role of basal cortisol. Psychoneuroendocrinology. 2014;47:107–115.
   PubMed Web of Science ®Google Scholar
• Snyder P. Effects of age on testicular function and consequences of testosterone treatment. J Clin Endocrinol Metab. 2001;86(6):2369–2372.
   PubMed Web of Science ®Google Scholar
• Rabijewski M, Jakiel G, Zgliczynski W. Zespól niedoboru testosteronu. Med Dypl. 2008;7:77–79.
   Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589–598.
   PubMed Web of Science ®Google Scholar
• Wu FC, Tajar A, Pye SR, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008;93(7):2737–2745.
   PubMed Web of Science ®Google Scholar
• Harman SM, Metter EJ, Tobin JD, et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore longitudinal study of aging. J Clin Endocrinol Metab. 2001;86(2):724–731.
   PubMed Web of Science ®Google Scholar
• Livigston M, Kalansooriya A, Hartland AJ, et al. Serum testosterone levels in male hypogonadism: Why and when to check a review. Int J Clin Pract. 2017;71:1–9.
   Web of Science ®Google Scholar
• Catakoglu AB, Kendirci M. Testosterone replacement therapy and cardiovascular events. Turk Kardyyol Dern Ars. 2017;45:664–672.
   PubMed Web of Science ®Google Scholar
• Klooner RA, Carson C, Dobs A, et al. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545–557.
   PubMed Web of Science ®Google Scholar
• Khripun I, Vorobyev S, Belousov I, et al. Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial. Aging Male. 2018;20:1–9.
   Google Scholar
• Hackett G, Cole N, Mulay Strange RC, et al. Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors. BJU Int. 2018;14:1–33.
   Google Scholar
• Traish AM, Haider A, Haider KS, et al. Long-term testosterone therapy improves Cardiometabolic function and reduces risk of Cardiovascular disease in men with Hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups. J Cardiovasc Pharmacol Ther. 2017 Sep;22(5):414–433.
   PubMed Web of Science ®Google Scholar
• Haider KS, Haider A, Doros G, et al. Long-term testosterone therapy improves urinary and sexual function, and quality of life in men with Hypogonadism: Results from a propensity matched subgroup of a controlled registry study. J Urol. 2018 Jan;199(1):257–265.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang X, Zhong Y, et al. Dynamic patterns of testosterone levels in individuals and risk of prostate cancer among Hypogonadal men: a longitudinal study. J Urol. 2018 Feb;199(2):465–473.
   PubMed Web of Science ®Google Scholar
• Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol. 2009 Feb;55(2):310–321.
   PubMed Web of Science ®Google Scholar
• Haider A, Yassin A, Haider KS, et al. Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study. Vasc Health Risk Manag. 2016 Jun;14(12):251–261.
   Google Scholar
• Zhang X, Zhong Y, Saad F, et al. Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels. Aging Male. 2019;12:1–7.
   Google Scholar
• Yassin A, Haider A, Haider KS, et al. Testosterone therapy in men with Hypogonadism prevents progression from prediabetes to type 2 diabetes: eight-year data from a registry study. Diabetes Care. 2019 Jun;42(6):1104–1111.
   PubMed Web of Science ®Google Scholar
• Saad F, Caliber M, Doros G, et al. Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortality. Aging Male. 2019;20:1–12.
   Web of Science ®Google Scholar
• Yassin A, Almehmadi Y, Alwani M. et al. Long-term Testosterone therapy improves renal function in men with Hypogonadism: a real-life prospective controlled registry. J Clin Nephrol Res. 2020;7(1):1095.
   Google Scholar
• Luboshitzky R, Aviv A, Hefetz A, et al. Decreased pituitary-gonadal secretion in men with obstructive sleep apnea. J Clin Endocrinol Metab. 2002;87(7):3394–3398.
   PubMed Web of Science ®Google Scholar
• Luboshitzky R, Zabari Z, Shen-Orr Z, et al. Disruption of the nocturnal testosterone rhythm by sleep fragmentation in normal men. J Clin Endocrinol Metab. 2001;86(3):1134–1139.
   PubMed Web of Science ®Google Scholar
• Barret-Connor E, Dam TT, Stone K, et al. The association of testosterone levels with overall sleep quality, sleep architecture, and sleep-disordered breathing. J Clin Endocrinol Metab. 2008;93(7):2602–2609.
   PubMed Web of Science ®Google Scholar
• Axelsson J, Ingre M, Akerstedt T, et al. Effects of acutely displaced sleep on testosterone. J Clin Endocrinol Metab. 2005;90(8):4530–4535.
   PubMed Web of Science ®Google Scholar
• Penev PD. Association between sleep and morning testosterone levels in older men. Sleep. 2007;30(4):427–432.
   PubMed Web of Science ®Google Scholar
• Schmid SM, Hallschmid M, Jauch-Chara K, et al. Sleep timing may modulate the effect of sleep loss on testosterone. Clin Endocrinol. 2012;77(5):749–754.
   PubMed Web of Science ®Google Scholar
• Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305(21):2173–2174.
   PubMed Web of Science ®Google Scholar
• Reynolds AC, Dorrian J, Liu PY, et al. Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men. PLoS One. 2012;7(7):412–418.
   Web of Science ®Google Scholar
• Goh VH, Tong TY. Sleep, sex steroid hormones, sexual activities, and aging in Asian men. J Androl. 2010;31(2):131–137.
   PubMedGoogle Scholar
• Burschtin O, Wang J. Testosterone deficiency and sleep apnea. Sleep Med Clin. 2016;11(4):525–529.
   PubMed Web of Science ®Google Scholar
• Shigehara K, Konaka H, Sugimoto K, et al. Sleep disturbance as a clinical sign for severe hypogonadism: efficacy of testosterone replacement therapy on sleep disturbance among hypogonadal men without obstructive sleep apnea. Aging Male. 2018 Jun;21(2):99–105.
   PubMed Web of Science ®Google Scholar
• Caminiti G, Volterrani M, Iellamo F. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol. 2009;54(10):919–927.
   PubMed Web of Science ®Google Scholar